Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers

BACKGROUND: Osteoarthritis (OA) is a slowly developing and debilitating disease, and there are no validated specific biomarkers for its early detection. To improve therapeutic approaches, identification of specific molecules/biomarkers enabling early determination of this disease is needed. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tardif, Ginette, Paré, Frédéric, Gotti, Clarisse, Roux-Dalvai, Florence, Droit, Arnaud, Zhai, Guangju, Sun, Guang, Fahmi, Hassan, Pelletier, Jean-Pierre, Martel-Pelletier, Johanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125906/
https://www.ncbi.nlm.nih.gov/pubmed/35606786
http://dx.doi.org/10.1186/s13075-022-02801-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125906/
https://www.ncbi.nlm.nih.gov/pubmed/35606786
http://dx.doi.org/10.1186/s13075-022-02801-1

Ejemplares similares